Evaluation of Acute Cardiovascular Effects of Esmolol in the Dog–awake and Anesthetized With Halothane and Enflurane

Gatt, Stephen; Hurley, R. Morrison; Fox, J.; Feldman, Hal S.; Möller, Reinhold; Covino, Benjamín G.

doi:10.1097/00000542-198409001-00017

Cited by 8 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The effects of esmolol dissipate to baseline within 30 minutes after its discontinuation. It has been shown that in doses greater than 100 mcg/kg, esmolol could cause moderate to severe depression of left ventricular function in anesthetized dogs 23 . The cardiovascular effects of esmolol were also studied by Menkhaus et al, 24 who showed that heart rate responses to induction and intubation were attenuated by esmolol.…”

Section: Discussionmentioning

confidence: 98%

Cardiopulmonary compromise after use of topical and submucosal α‐agonists: Possible added complication by the use of β‐blocker therapy

Kalyanaraman

Carpenter

McGlew

et al. 1997

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

We report the specifics of 12 cases of severe hypertension after the intraoperative use of topical phenylephrine, submucosal epinephrine, or both. Ten of these 12 patients also developed severe pulmonary edema. Seven of the twelve were treated with β blockers; 3 of whom suffered cardiac arrest. We propose a common mechanism: the vasoconstrictors caused systemic hypertension, increased left ventricular afterload, decreased left ventricular compliance, and decreased cardiac output. In those patients treated with β blockers, decreased contractility and inability to increase heart rate further compromised cardiopulmonary function. (Otolaryngol Head Neck Surg 1997;117:56–61.)

show abstract

Section: Discussionmentioning

confidence: 98%

Cardiopulmonary compromise after use of topical and submucosal α‐agonists: Possible added complication by the use of β‐blocker therapy

Kalyanaraman

Carpenter

McGlew

et al. 1997

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

show abstract

Interactions of Volatile Anesthetics with Epinephrine, ß-Receptor Antagonists and Calcium Channel Blockers

Prys‐Roberts¹

1987

Inhalation Anesthetics

View full text Add to dashboard Cite

Interaktionen volatiler Anästhetika mit Epinephrin, β-Rezeptorenblockern und Kalziumantagonisten

Prys‐Roberts¹

1986

Inhalationsanaesthetika

View full text Add to dashboard Cite

Evaluation of Acute Cardiovascular Effects of Esmolol in the Dog–awake and Anesthetized With Halothane and Enflurane

Cited by 8 publications

References 0 publications

Cardiopulmonary compromise after use of topical and submucosal α‐agonists: Possible added complication by the use of β‐blocker therapy

Cardiopulmonary compromise after use of topical and submucosal α‐agonists: Possible added complication by the use of β‐blocker therapy

Interactions of Volatile Anesthetics with Epinephrine, ß-Receptor Antagonists and Calcium Channel Blockers

Interaktionen volatiler Anästhetika mit Epinephrin, β-Rezeptorenblockern und Kalziumantagonisten

Contact Info

Product

Resources

About